The design and synthesis of the high efficacy, non-peptide CCK1 receptor agonist PD 170292

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 11, 2000, Pages 1245-1248

  Bernad, N ^a   Burgaud, B G M ^b   Horwell, D C ^b   Lewthwaite, R A ^b   Martinez, J ^a   Pritchard, M C ^b  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; N TERT BUTYLOXYCARBONYLCHOLECYSTOKININ[27-32][28,31 NORLEUCINE] PHENETHYL ESTER; PD 170292; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; NONHUMAN; RAT; RECOGNITION;

ADAMANTANE; ANIMALS; CITRULLINE; PEPTOIDS; RATS; RECEPTORS, CHOLECYSTOKININ;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0034608531     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00198-0     Document Type: Article

References (17)

1. For a recent review see Pritchard, M. C.; Raphy, J.; Singh, L. Exp. Opin. Invest. Drugs 1997, 6, 349.
2. 1 receptor agonists see de Tullio, P.; Delarge, J. D.; Pirotte, B. Curr. Med. Chem. 1999, 6, 433.
3. 1 receptor agonists Bignon, E.; Bachy, A.; Boigegrain, R.; Brodin, R.; Cottineau, M.; Gully, D.; Herbert, J.; Keane, P.; Labie, C.; Molimard, J.; Olliero, D.; Oury-Donat, F.; Petereau, C.; Prabonnaud, V.; Rockstroh, M.; Schaeffer, P.; Servant, O.; Thurneyssen, O.; Soubrie, P.; Pascal, M.; Maffrand, J.; Le Fur, G. J. Pharmacol. Experimental Therapeutics 1999, 289, 742.
4. See Holladay, M. W.; Kopecka, H.; Miller, T. R.; Bednarz, L.; Nikkel, A. L.; Bianchi, B. R.; Witte, D. G.; Shiosaki, K.; Wel Lin, C.; Asin, K. E.; Nadzan, A. M. J. Med. Chem. 1994, 37, 630 and references cited therein.
5. (a) Bourne, G. T., Horwell, D. C., Pritchard, M. C. Bioorg. Med. Chem. Lett. 1993, 3, 889.
6. (b) Burgaud, B. G. M.; Horwell, D. C.; Pritchard, M. C.; Bernad, N.; Martinez, J.-M. Tetrahedron: Asymmetry 1995, 6, 1081.
7. Galas M.G., Lignon M.F., Rodriguez M., Mendre C., Fulcrand P., Laur J., Martinez J. Am. J. Physiol. 254:1988;G176.
8. Horwell D.C., Hughes J., Hunter J.C., Pritchard M.C., Richardson R.S., Roberts E., Woodruff G.N. J. Med. Chem. 34:1991;404.
9. Hughes J., Dockray G.J., Hill D., Garcia L., Pritchard M.C., Forster E., Toescu E., Woodruff G.N., Horwell D.C. Regul. Peptides. 65:1996;15.
10. Dezube M., Sugg E.E., Birkemo L.S., Croom D.K., Dougherty R.W., Ervin G.N., Grizzle M.K., James M.K., Johnson M.F., Mosher J.T., Queen K.L., Rimele T.J., Sauls H.R., Triantafillou J.A. J. Med. Chem. 38:1995;3884.
11. Sankaran H., Goldfine I.D., Bailey A., Licko V., Williams J.A. Am. J. Physiol. 242:1982;G250.
12. Sankaran H., Goldfine I.D., Deveney C.W., Wong E.Y., Williams J.A. J. Biol. Chem. 255:1980;1849.
13. Martinez, J.; Galas, M. C.; Lignon, M. F.; Rodriguez, M.; Fulcrand, P. In CCK Antagonists in Gastroenterology, Adler G.; Beglinger, C., Eds.; Springer: Berlin, Heidelberg, 1991; pp 80-90.
14. Lignon M.F., Galas M.F., Rodriguez M., Martinez J. Cellular Signalling. 2:1990;339.
15. 1). Values given represent the arithmetic mean from at least 3 experiments. For full experimental details see ref 6.
16. Jensen R.T., Lemp G.F., Gardner G.D. J. Biol. Chem. 257:1982;5554.
17. +) found 672.3757.